Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients

Abstract Background Lung cancer ranks as the leading cause of cancer-related deaths worldwide and we performed this meta-analysis to investigate eligible studies and determine the prognostic effect of Ki-67. Methods In total, 108 studies in 95 articles with 14,732 patients were found to be eligible,...

Full description

Bibliographic Details
Main Authors: Dan-ming Wei, Wen-jie Chen, Rong-mei Meng, Na Zhao, Xiang-yu Zhang, Dan-yu Liao, Gang Chen
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Respiratory Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12931-018-0843-7
_version_ 1828880749221117952
author Dan-ming Wei
Wen-jie Chen
Rong-mei Meng
Na Zhao
Xiang-yu Zhang
Dan-yu Liao
Gang Chen
author_facet Dan-ming Wei
Wen-jie Chen
Rong-mei Meng
Na Zhao
Xiang-yu Zhang
Dan-yu Liao
Gang Chen
author_sort Dan-ming Wei
collection DOAJ
description Abstract Background Lung cancer ranks as the leading cause of cancer-related deaths worldwide and we performed this meta-analysis to investigate eligible studies and determine the prognostic effect of Ki-67. Methods In total, 108 studies in 95 articles with 14,732 patients were found to be eligible, of which 96 studies reported on overall survival (OS) and 19 studies reported on disease-free survival (DFS) with relation to Ki-67 expression in lung cancer patients. Results The pooled hazard ratio (HR) indicated that a high Ki-67 level could be a valuable prognostic factor for lung cancer (HR = 1.122 for OS, P < 0.001 and HR = 1.894 for DFS, P < 0.001). Subsequently, the results revealed that a high Ki-67 level was significantly associated with clinical parameters of lung cancer including age (odd ratio, OR = 1.246 for older patients, P = 0.018), gender (OR = 1.874 for males, P < 0.001) and smoking status (OR = 3.087 for smokers, P < 0.001). Additionally, significant positive correlations were found between Ki-67 overexpression and poorer differentiation (OR = 1.993, P = 0.003), larger tumor size (OR = 1.436, P = 0.003), and higher pathologic stages (OR = 1.867 for III-IV, P < 0.001). Furthermore, high expression of Ki-67 was found to be a valuable predictive factor for lymph node metastasis positive (OR = 1.653, P < 0.001) and advanced TNM stages (OR = 1.497 for stage III-IV, P = 0.024). Finally, no publication bias was detected in any of the analyses. Conclusions This study highlights that the high expression of Ki-67 is clinically relevant in terms of the prognostic and clinicopathological characteristics for lung cancer. Nevertheless, more prospective well-designed studies are warranted to validate these findings.
first_indexed 2024-12-13T09:54:47Z
format Article
id doaj.art-e7b84b31c3554a51a6f82d45f316a349
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-12-13T09:54:47Z
publishDate 2018-08-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-e7b84b31c3554a51a6f82d45f316a3492022-12-21T23:51:50ZengBMCRespiratory Research1465-993X2018-08-0119111910.1186/s12931-018-0843-7Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patientsDan-ming Wei0Wen-jie Chen1Rong-mei Meng2Na Zhao3Xiang-yu Zhang4Dan-yu Liao5Gang Chen6Department of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityAbstract Background Lung cancer ranks as the leading cause of cancer-related deaths worldwide and we performed this meta-analysis to investigate eligible studies and determine the prognostic effect of Ki-67. Methods In total, 108 studies in 95 articles with 14,732 patients were found to be eligible, of which 96 studies reported on overall survival (OS) and 19 studies reported on disease-free survival (DFS) with relation to Ki-67 expression in lung cancer patients. Results The pooled hazard ratio (HR) indicated that a high Ki-67 level could be a valuable prognostic factor for lung cancer (HR = 1.122 for OS, P < 0.001 and HR = 1.894 for DFS, P < 0.001). Subsequently, the results revealed that a high Ki-67 level was significantly associated with clinical parameters of lung cancer including age (odd ratio, OR = 1.246 for older patients, P = 0.018), gender (OR = 1.874 for males, P < 0.001) and smoking status (OR = 3.087 for smokers, P < 0.001). Additionally, significant positive correlations were found between Ki-67 overexpression and poorer differentiation (OR = 1.993, P = 0.003), larger tumor size (OR = 1.436, P = 0.003), and higher pathologic stages (OR = 1.867 for III-IV, P < 0.001). Furthermore, high expression of Ki-67 was found to be a valuable predictive factor for lymph node metastasis positive (OR = 1.653, P < 0.001) and advanced TNM stages (OR = 1.497 for stage III-IV, P = 0.024). Finally, no publication bias was detected in any of the analyses. Conclusions This study highlights that the high expression of Ki-67 is clinically relevant in terms of the prognostic and clinicopathological characteristics for lung cancer. Nevertheless, more prospective well-designed studies are warranted to validate these findings.http://link.springer.com/article/10.1186/s12931-018-0843-7Ki-67Lung cancerMeta-analysisPrognosisClinicopathological characteristics
spellingShingle Dan-ming Wei
Wen-jie Chen
Rong-mei Meng
Na Zhao
Xiang-yu Zhang
Dan-yu Liao
Gang Chen
Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
Respiratory Research
Ki-67
Lung cancer
Meta-analysis
Prognosis
Clinicopathological characteristics
title Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
title_full Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
title_fullStr Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
title_full_unstemmed Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
title_short Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
title_sort augmented expression of ki 67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients an up dated systematic review and meta analysis with 108 studies and 14 732 patients
topic Ki-67
Lung cancer
Meta-analysis
Prognosis
Clinicopathological characteristics
url http://link.springer.com/article/10.1186/s12931-018-0843-7
work_keys_str_mv AT danmingwei augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients
AT wenjiechen augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients
AT rongmeimeng augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients
AT nazhao augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients
AT xiangyuzhang augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients
AT danyuliao augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients
AT gangchen augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients